Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06299540 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia

Study acronym: QOLIBRI
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 25, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Completion pushed from Oct 29, 2027 to Nov 30, 2027 Eligibility criteria expanded, about 10 words · Secondary endpoints: details revised at 17 of 32 entries Show 2 more changesShow less
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 17 of 32 entries
  2. 6 versions Re-verified since Mar 12, 2026, no change to tracked fieldsv22-v27
  3. Site details revisedv21
  4. Re-verified, no change to tracked fieldsv20
  5. Enrollment target: 256 to 180 Completion date: Aug 31, 2027 to Oct 29, 2027 · Secondary endpoints: 33 to 32v19 Show 2 more changesShow less
    • Completion date: Aug 31, 2027 to Oct 29, 2027
    • Secondary endpoints: 33 to 32

    See this version in full on ClinicalTrials.gov ↗

Show 17 earlier versionsHide 17 earlier versions
  1. 3 versions Re-verified since Jul 17, 2025, no change to tracked fieldsv16-v18
  2. Completion date: Jun 30, 2027 to Aug 31, 2027v15
  3. 5 versions Re-verified since Dec 6, 2024, no change to tracked fieldsv10-v14
  4. Completion date: Dec 31, 2026 to Jun 30, 2027v9
  5. 3 versions Re-verified since Jul 16, 2024, no change to tracked fieldsv6-v8
  6. Completion date: Sep 30, 2026 to Dec 31, 2026 Start date changed from estimate of May 15, 2024 to May 27, 2024v5 Show 1 more changeShow less
    • Start date changed from estimate of May 15, 2024 to May 27, 2024
  7. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date: Apr 30, 2024 to May 15, 2024v4 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date: Apr 30, 2024 to May 15, 2024
  8. Start date: Mar 29, 2024 to Apr 30, 2024v3
  9. Start date: Mar 5, 2024 to Mar 29, 2024v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to assess the impact of an individual physical activity intervention (IPAI) on health-related quality of life (HRQoL) in participants with first line or relapsed chronic lymphocytic leukemia (CLL) initiating ibrutinib in a routine clinical practice setting. HRQoL will be measured using functional assessment of cancer therapy - general scale (FACT-G).
Trial Details
NCT Number NCT06299540
Lead Sponsor Janssen Cilag S.A.S.
Conditions Leukemia, Lymphocytic, Chronic, B-Cell
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov